Trial Profile
Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary) ; Finasteride
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- Acronyms EPICS
- 22 Jul 2011 New trial record
- 01 Jun 2011 Results published in BJU International.